| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | Japan | 3 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Foods and drinks | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Foods | |
| #5 | Special foods | |
| #6 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Umezawa Kazuo | 11 |
| #2 | Koyano Takashi | 5 |
| #3 | Kojima Itaru | 3 |
| #4 | Horiguchi Yutaka | 2 |
| #5 | Ohgawara Hisako | 2 |
| #6 | Horie Ryouichi | 2 |
| #7 | Nakashima Jun | 2 |
| #8 | Takei Izumi | 2 |
| #9 | Fujii Mikio | 1 |
| #10 | Itabashi Maki | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2010286184A1 | Aqueous solution of conophylline and/or conophyllidine | |
| US2006167086A1 | Medicinal composition | |
| JP2000281698A | Physiologically active substance furcreastatin and carcinostatic agent | |
| JPH11322602A | Inhibitor of transcription factor nfkappab activation | |
| JPH0687736A | Anticancer agent |